Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Mylan NV (NASDAQ:MYL)

46.48
Delayed Data
As of 3:59pm ET
 -0.80 / -1.69%
Today’s Change
37.59
Today|||52-Week Range
58.05
-14.04%
Year-to-Date
Where Is the Insider Buying?
Jul 25 / TheStreet.com - Paid Partner Content
The Zacks Analyst Blog Highlights: Manulife Financial, Mylan, Huntsman, Air Lease and...
Jul 18 / Zacks.com - Paid Partner Content
5 Incredibly Cheap Big Pharma Stocks
Jul 25 / MotleyFool.com - Paid Partner Content
6 Stocks Still Trading Cheap in Today's Market
Jul 15 / Zacks.com - Paid Partner Content
3 Stocks Pushing The Drugs Industry Downward
Jul 21 / TheStreet.com - Paid Partner Content
Teva (TEVA) Provides 2016-2019 Outlook, Shares Gain
Jul 14 / Zacks.com - Paid Partner Content
Stock Market News for July 21, 2016
Jul 21 / Zacks.com - Paid Partner Content
Biosimilars set topple two of the world's biggest drug franchises
Jul 14 / FT.com - Paid Partner Content
Roche Beats First-Half Forecasts as Cancer Drug Sales Rise
Jul 21 / TheStreet.com - Paid Partner Content
Looking For Generic Drug Stocks? Pick Up These Winners
Jul 13 / Zacks.com - Paid Partner Content
Barbarian At The Gate: Mylan (MYL)
Jul 20 / TheStreet.com - Paid Partner Content
Teva Raises Q2 Guidance; to Unveil 2016-2019 View
Jul 13 / Zacks.com - Paid Partner Content
Mylan Gets EC Clearance for Meda Purchase
Jul 20 / TheStreet.com - Paid Partner Content